Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression.

Tauopathies are degenerative diseases characterized by the accumulation of phosphorylated tau in neurons and glial cells. With some exceptions, tau deposits in neurons are mainly manifested as pretangles and tangles unrelated to the tauopathy. It is thought that abnormal tau deposition in neurons occurs following specific steps, but little is known about the progression of tau pathology in glial cells in tauopathies. We compared tau pathology in different astrocyte phenotypes and oligodendroglial inclusions with that in neurons in a large series of tauopathies, including progressive supranuclear palsy, corticobasal degeneration, argyrophilic grain disease, Pick disease, frontotemporal lobar degenerations (FTLD) associated with mutations in the tau gene, globular glial tauopathy (GGT), and tauopathy in the elderly. Our findings indicate that disease-specific astroglial phenotypes depend on i) the primary amino acid sequence of tau (mutated tau, 3Rtau, and 4Rtau); ii) phospho-specific sites of tau phosphorylation, tau conformation, tau truncation, and ubiquitination in that order (which parallel tau modifications related to pretangle and tangle stages in neurons); and iii) modifications of the astroglial cytoskeleton. In contrast to astrocytes, coiled bodies in oligodendrocytes have similar characteristics whatever the tauopathy, except glial globular inclusions in GGT, and coiled bodies and globular oligodendroglial inclusions in FTLD-tau/K317M. These observations indicate that tau pathology in glial cells largely parallels, but is not identical to, that in neurons in many tauopathies.

[1]  D. Dickson,et al.  Argyrophilic Grain Disease Is a Sporadic 4‐Repeat Tauopathy , 2002, Journal of neuropathology and experimental neurology.

[2]  A. Delacourte,et al.  Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms , 2002, Acta Neuropathologica.

[3]  Mark A. Smith,et al.  Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease , 2008, International journal of experimental pathology.

[4]  J. Luna-Muñoz,et al.  Stages of Pathological Tau-Protein Processing in Alzheimer’s Disease: From Soluble Aggregations to Polymerization into Insoluble Tau-PHFs , 2009 .

[5]  M. Goedert,et al.  Pathogenesis of the Tauopathies , 2011, Journal of Molecular Neuroscience.

[6]  E. Tolosa,et al.  Ubiquitin-negative mini-pick-like bodies in the dentate gyrus in p301l tauopathy. , 2004, Journal of Alzheimer's disease : JAD.

[7]  Dennis W. Dickson,et al.  Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease , 2002, Acta Neuropathologica.

[8]  F. García-Sierra,et al.  Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.

[9]  Mari Yoshida,et al.  Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[10]  A. Delacourte,et al.  Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP‐17 and Pick's Disease , 1999, Brain pathology.

[11]  K. Arima Ultrastructural characteristics of tau filaments in tauopathies: Immuno‐electron microscopic demonstration of tau filaments in tauopathies , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[12]  P. Hof,et al.  Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick’s disease , 1996, Acta Neuropathologica.

[13]  Isidro Ferrer,et al.  Argyrophilic grain disease. , 2008, Brain : a journal of neurology.

[14]  Isidre Ferrer,et al.  Characterization of Thorn‐Shaped Astrocytes in White Matter of Temporal Lobe in Alzheimer's Disease Brains , 2013, Brain pathology.

[15]  Dennis W. Dickson,et al.  Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau) , 2011, Journal of Molecular Neuroscience.

[16]  E. Bigio,et al.  Phosphorylation and cleavage of tau in non-AD tauopathies , 2007, Acta Neuropathologica.

[17]  P. Pástor,et al.  Multiple cervical artery dissections , 2005, Neurology.

[18]  D. Dickson,et al.  Frontal Lobe Dementia With Novel Tauopathy: Sporadic Multiple System Tauopathy With Dementia , 2001, Journal of neuropathology and experimental neurology.

[19]  Allissa Dillman,et al.  MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies , 2012, Human molecular genetics.

[20]  G. Sobue,et al.  Distribution of tuft-shaped astrocytes in the cerebral cortex in progressive supranuclear palsy , 2004, Acta Neuropathologica.

[21]  F. García-Sierra,et al.  Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.

[22]  B. Ghetti,et al.  White Matter Tauopathy With Globular Glial Inclusions: A Distinct Sporadic Frontotemporal Lobar Degeneration , 2008, Journal of neuropathology and experimental neurology.

[23]  Miklós Palkovits,et al.  A peculiar constellation of tau pathology defines a subset of dementia in the elderly , 2011, Acta Neuropathologica.

[24]  E. Mandelkow,et al.  Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model , 2007, Proceedings of the National Academy of Sciences.

[25]  J. Newcombe,et al.  Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies , 2011, Acta Neuropathologica.

[26]  G. Perry,et al.  Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology , 2007, Neuropathology and applied neurobiology.

[27]  D. Řípová,et al.  Ubiquitin is Associated with Early Truncation of Tau Protein at Aspartic Acid421 during the Maturation of Neurofibrillary Tangles in Alzheimer's Disease , 2012, Brain pathology.

[28]  K. Arima,et al.  Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy , 1997, Acta Neuropathologica.

[29]  J. DeFelipe Cajal's Butterflies of the Soul , 2009 .

[30]  R. Berry,et al.  Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. , 2003, Journal of Alzheimer's disease : JAD.

[31]  M. Mesulam,et al.  The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy , 2003, Acta Neuropathologica.

[32]  R A Crowther,et al.  Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  I. Ferrer,et al.  Neuropathology of hereditary forms of frontotemporal dementia and parkinsonism. , 2008, Handbook of clinical neurology.

[34]  E. Mandelkow,et al.  Proteolytic processing of tau. , 2010, Biochemical Society transactions.

[35]  Dennis W. Dickson,et al.  Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process , 2002, Acta Neuropathologica.

[36]  S. R. Cajal Textura del Sistema Nervioso del Hombre y de los Vertebrados, 1899–1904 , 2019 .

[37]  D. Kareken,et al.  The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family , 2007, Brain : a journal of neurology.

[38]  T. Tokuda,et al.  Thorn-shaped astrocytes: possibly secondarily induced tau-positive glial fibrillary tangles , 2004, Acta Neuropathologica.

[39]  R A Crowther,et al.  Tau pathology in a family with dementia and a P301L mutation in tau. , 1999, Journal of neuropathology and experimental neurology.

[40]  O. Yokota,et al.  Pick's disease. , 2012, Advances in experimental medicine and biology.

[41]  M. Barrachina,et al.  Brain banks: benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies , 2008, Cell and Tissue Banking.

[42]  Jennifer L. Whitwell,et al.  Corticobasal degeneration: a pathologically distinct 4R tauopathy , 2011, Nature Reviews Neurology.

[43]  Udo Rüb,et al.  High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe , 2004, Neurobiology of Aging.

[44]  D. Dickson,et al.  Neuropathology of variants of progressive supranuclear palsy. , 2010, Current opinion in neurology.

[45]  V. Matyash,et al.  Heterogeneity in astrocyte morphology and physiology , 2010, Brain Research Reviews.

[46]  B. Barres,et al.  Astrocyte heterogeneity: an underappreciated topic in neurobiology , 2010, Current Opinion in Neurobiology.

[47]  T. Hortobágyi,et al.  Neuropathology of the hippocampus in FTLD‐Tau with Pick bodies: a study of the BrainNet Europe Consortium , 2013, Neuropathology and applied neurobiology.

[48]  T. Uchihara,et al.  Specific Detection of Pathological Three‐repeat Tau after Pretreatment with Potassium Permanganate and Oxalic Acid in PSP/CBD Brains , 2011, Brain pathology.

[49]  G. Schellenberg,et al.  A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) , 1999, Brain : a journal of neurology.

[50]  M. Novák,et al.  Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease. , 2010, Current Alzheimer research.